← Back to patent-cliff list
对乙酰氨基酚/马来酸氯苯那敏/盐酸甲基麻黄碱/愈创木酚磺酸钾/咖啡因
Tier C — Watch / tradeAcetaminophen/Chlorphenamine Maleate/Methylephedrine Hydrochloride/Sulfogaiacol/Caffeine
-
Originator
2006
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：COXs、HRH1、Adrenoceptors、ADORA1、ADORA2A
Indications (approved)：感冒
Regional status
US
-
EU
-
China
批准上市
2006-05-16
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Acetaminophen/Chlorphenamine Maleate/Methylephedrine Hydrochloride/Sulfogaiacol/Caffeine?
Approved indications include: 感冒.
When does the Acetaminophen/Chlorphenamine Maleate/Methylephedrine Hydrochloride/Sulfogaiacol/Caffeine patent expire?
No public expiry year is available for Acetaminophen/Chlorphenamine Maleate/Methylephedrine Hydrochloride/Sulfogaiacol/Caffeine yet; this page updates once verified.
How do I get a quote for Acetaminophen/Chlorphenamine Maleate/Methylephedrine Hydrochloride/Sulfogaiacol/Caffeine intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24